Latest News and Press Releases
Want to stay updated on the latest news?
-
Zenas BioPharma investors have until June 16 to sign up to become a Lead Plaintiff in this securities class action. For more information, call Molly Bowen.
-
Cohen Milstein continues lead plaintiff Search for Zenas BioPharma (ZBIO) securities fraud class action. Contact Molly Bowen, Esq. at 1 (202) 408-4600.
-
Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit
Cohen Milstein reminds Zenas BioPharma (ZBIO) investors of an opportunity to lead a securities fraud class action. Lead plaintiff deadline - June 16, 2025.
-
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI) complied with...
-
SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of DXC Technology Company (NYSE: DXC) (“DXC” or the “Company”) common stock...
-
If you purchased Lamb Weston common stock between July 25, 2023 and April 3, 2024, and suffered substantial losses, contact DiCello Levitt.
-
SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
-
SAN DIEGO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise...
-
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that...
-
SAN DIEGO, April 26, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins L6/17LP reminds investors that a shareholder filed a class action on behalf of all persons and entities...